Table 3.
Between-group comparisons of patient satisfaction by condition.
| Areas | Statements | Patient conditions/group | Intervention median satisfaction score (mean transformed satisfaction score) | Control median satisfaction score (mean transformed satisfaction score) | Difference (intervention — control) in mean transformed satisfaction score (95% CI) | P-value |
|---|---|---|---|---|---|---|
| Collection process | I would rather have blood taken by a finger prick than by needle in my arm | All conditions | 7.8 (0.92) | 5.1 (1.64) | −0.73 (−0.89 to −0.57) | <0.001 |
| Anticoagulant therapy | 8.7 (0.36) | 5.0 (1.60) | −1.24 (−1.49 to −0.98) | <0.001 | ||
| Diabetes | 7.8 (0.87) | 5.9 (1.46) | −0.59 (−0.80 to −0.39) | <0.001 | ||
| Hyperlipidaemia | 7.7 (0.98) | 5.0 (1.68) | −0.70 (−0.87 to −0.53) | <0.001 | ||
| Confidence in the process | Laboratories have better hygiene than point-of-care testing | All conditions | 4.3 (1.65) | 4.6 (2.07) | −0.43 (−0.62 to −0.23) | <0.001 |
| Anticoagulant therapy | 3.4 (1.41) | 4.8 (2.00) | −0.59 (−0.87 to −0.30) | <0.001 | ||
| Diabetes | 4.3 (1.71) | 4.6 (2.09) | −0.39 (−0.67 to −0.11) | 0.007 | ||
| Hyperlipidaemia | 4.3 (1.66) | 4.7 (2.09) | −0.43 (−0.63 to −0.23) | <0.001 | ||
| Confidence in the results | I have confidence in the information given by my GP or practice regarding my pathology test result | All conditions | 9.0 (0.06) | 8.9 (0.18) | −0.12 (−0.21 to −0.03) | 0.010 |
| Anticoagulant therapy | 9.1 (−0.05) | 8.9 (0.12) | −0.16 (−0.32 to −0.01) | 0.039 | ||
| Diabetes | 9.1 (−0.01) | 8.9 (0.18) | −0.18 (−0.32 to −0.04) | 0.010 | ||
| Hyperlipidaemia | 8.9 (0.08) | 8.9 (0.20) | −0.12 (−0.21 to −0.02) | 0.018 | ||
| Convenience | Not having to travel to an outside laboratory would be convenient | All conditions | 8.9 (0.17) | 8.7 (0.36) | −0.20 (−0.34 to −0.05) | 0.009 |
| Anticoagulant therapy | 9.0 (0.04) | 8.7 (0.37) | −0.33 (−0.58 to −0.07) | 0.012 | ||
| Diabetes | 8.9 (0.14) | 8.8 (0.33) | −0.19 (−0.36 to −0.01) | 0.033 | ||
| Hyperlipidaemia | 8.8 (0.20) | 8.5 (0.38) | −0.18 (−0.34 to −0.03) | 0.021 | ||
| Cost | Outside pathology laboratories involves extra time and transport costs | All conditions | 8.5 (0.44) | 8.6 (0.39) | 0.06 (−0.11 to 0.23) | 0.51 |
| Anticoagulant therapy | 8.7 (0.38) | 8.8 (0.42) | −0.04 (−0.33 to 0.24) | 0.76 | ||
| Diabetes | 8.5 (0.41) | 8.6 (0.35) | 0.06 (−0.13 to 0.26) | 0.54 | ||
| Hyperlipidaemia | 8.4 (0.46) | 8.5 (0.41) | 0.05 (−0.12 to 0.22) | 0.56 | ||
| Disease management | Having immediate feedback of the test result for my condition was important as it allowed/would allow me to discuss the management of my condition with my GP | All conditions | 9.0 (0.12) | 8.7 (0.30) | −0.18 (−0.30 to −0.06) | 0.003 |
| Anticoagulant therapy | 9.2 (−0.10) | 9.0 (0.27) | −0.37 (−0.59 to −0.15) | <0.001 | ||
| Diabetes | 9.1 (−0.00) | 8.8 (0.25) | −0.26 (0.41 to −0.11) | <0.001 | ||
| Hyperlipidaemia | 9.0 (0.17) | 8.6 (0.34) | −0.17 (−0.29 to −0.05) | 0.006 | ||
| I am/would be more motivated to look after my condition because of regular point-of-care testing | All conditions | 8.9 (0.29) | 8.2 (0.64) | −0.36 (−0.49 to −0.22) | <0.001 | |
| Anticoagulant therapy | 9.1 (0.11) | 8.6 (0.59) | −0.48 (−0.70 to −0.25) | <0.001 | ||
| Diabetes | 9.0 (0.22) | 8.2 (0.59) | −0.37 (−0.55 to −0.20) | <0.001 | ||
| Hyperlipidaemia | 8.9 (0.32) | 8.2 (0.66) | −0.34 (−0.49 to −0.19) | <0.001 | ||
| Point-of-care testing strengthened/would strengthen my relationship with my GP | All conditions | 8.3 (0.52) | 8.1 (0.72) | −0.20 (−0.35 to −0.05) | 0.010 | |
| Anticoagulant therapy | 8.7 (0.37) | 8.4 (0.65) | −0.28 (−0.52 to −0.04) | 0.024 | ||
| Diabetes | 8.7 (0.41) | 8.3 (0.66) | −0.25 (−0.43 to −0.06) | 0.010 | ||
| Hyperlipidaemia | 8.3 (0.55) | 8.0 (0.75) | −0.20 (−0.35 to −0.05) | 0.008 | ||
Note: a lower transformed score indicates a higher level of agreement except for the hypothesis relating to confidence in the process, where a higher transformed score indicates a higher level of agreement.